May 5, 2020
Join our monthly live webinars to interact with our scientists. Vigene's viral vector and plasmid production technology webinar series
March 27, 2020
Vigene has joined the fight against COVID-19 by helping manufacture vaccines for COVID-19.
March 23, 2020
We would like to update you on the precautions and actions that Vigene Biosciences is taking due to the rapidly […]
February 27, 2020
BioBuzz reported on the grand opening of Vigene Biosciences’s new 51,000 square feet GMP manufacturing facility.
Vigene partners with Virovek for cGMP BAC-to-AAV production technology
Virovek has granted Vigene an exclusive cGMP license for their proprietary BAC-to-AAV production technology. AAV vectors generated from this scalable and efficient platform have been proven to infect and transduce a myriad of mammalian cell lines in vitro and a broad range of cell types in vivo.
Get the information you need from our guides and safety data sheets.
Citations & Testimonials
Find out how scientists are using our products and services.